PERSPECTA

News from every angle

← Back to headlines

Incyte fails to win FDA label expansion for cancer therapy due to issues at Novo plant

7 Mar, 14:20 — 7 Mar, 14:20
PostShare

Sources

Showing 1 of 1 sources